The article reports on the slackening of the human embryonic stem-cell (ES) research guidelines of Japan. It mentions that the new rule remove the secondary approval step for working with ES cell lines. However, it relates that the move might be too late since most of the state's stem-cell researches have already been pushed into iPS-cell research.